13F

Stock

Biomarin Pharmaceutical Inc

BMRN · held by 13 managers

Reported value

$263.2M

Holders

13

+0 new · −0 exited

Holders’ est. mark

−$5.98M

Price effect on 7 books still in the name

Largest holder

$233.9M

NORGES BANK

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
NORGES BANK3.31M$233.9MHeld
BARCLAYS PLC647.8K$19.7M−$6.48MCut−$2.07M
DANSKE BANK A/S84.6K$5.98M$397.3KAdded$713.9K
OP Asset Management Ltd20.5K$1.45MHeld
Swiss Life Asset Management Ltd16.5K$1.17M$59.2KAdded$399.8K
Leonteq Securities AG5.09K$360.3K$26KCut−$428.8K
Burton Enright Welch3.67K$259.7K$18.2KAdded$17.6K
VIRTUS ADVISERS, LLC37.9K$235.8KHeld
Sanctuary Advisors, LLC2.99K$211.4KHeld
Prestige Wealth Management Group LLC76$5.37K$169Added$3.14K
Aventura Private Wealth, LLC49$3.46K$243Added$243

Positions as of Q1 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.